Plasma total homocysteine and memory in the elderly: The Hordaland homocysteine study

Annals of Neurology

Volumn 58, Issue 6, 2005, Pages 847-857

  Nurk, Eha ^a   Refsum, Helga ^a,b   Tell, Grethe S ^c,d   Engedal, Knut ^e   Vollset, Stein E ^c,d   Ueland, Per M ^b,c   Nygaard, Harald A ^d   Smith, A David ^a,f  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Institute of Medicine

^c LOCUS for Homocysteine and Related Vitamins ^*  (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AGED; AMNESIA; ARTICLE; BLOOD LEVEL; DEMENTIA; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; KENDRICK OBJECT LEARNING TEST; MALE; MEMORY; NON INVASIVE MEASUREMENT; NORMAL HUMAN; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; MALE; MEMORY; MEMORY DISORDERS; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN B 12;

EID: 28544447509     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20645     Document Type: Article

References (73)

1. Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004;50:3-32.
2. Joosten E, van den Berg A, Riezler R, et al. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr 1993;58:468-476.
3. Selhub J, Jacques PF, Wilson PWF, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-2698.
4. Nilsson K, Gustafson L, Fäldt R, et al. Hyperhomocysteinaemia: a common finding in a psychogeriatric population. Eur J Clin Invest 1996;26:853-859.
5. Joosten E, Lesaffre E, Riezler R, et al. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol 1997;52A: M76-M79.
6. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449-1455.
7. McCaddon A, Davies G, Hudson P, et al. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998;13:235-239.
8. McIroy SP, Dynan KB, Lawson JT, et al. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002;33:2351-2356.
9. Smith AD. Homocysteine, B vitamins, and cognitive deficit in the elderly. Am J Clin Nutr 2002;75:785-786.
10. Morris MS. Homocysteine and Alzheimer's disease. Lancet Neurol 2003;2:425-428.
11. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
12. Riggs KM, Spiro A III, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996;63:306-314.
13. Lehmann M, Gottfries CG, Regland B. Identification of cognitive impairment in the elderly, homocysteine is an early marker. Dement Geriatr Cogn Disord 1999;10:12-20.
14. Budge M, Johnston C, Hogervorst E, et al. Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann N Y Acad Sci 2000;903:407-410.
15. McCaddon A, Hudson P, Davies G, et al. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001;12:309-313.
16. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2001;73:927-933.
17. Budge MM, de Jager C, Hogervorst E, Smith AD. Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc 2002;50: 2014-2018.
18. Duthie SJ, Whalley LJ, Collins AR, et al. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2002;75:908-913.
19. Prins ND, den Heijer T, Hofman A, et al. Homocysteine and cognitive function in the elderly. The Rotterdam Scan Study. Neurology 2002;59:1375-1380.
20. Stewart R, Asonganyi B, Sherwood R. Plasma homocysteine and cognitive impairment in an older British African-Caribbean population. J Am Geriatr Soc 2002;50:1227-1232.
21. Ravaglia G, Forti P, Maioli F, et al. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am J Clin Nutr 2003;77:668-673.
22. Teunissen CE, Blom AHJ, Van Boxtel MPJ, et al. Homocysteine: a marker for cognitive performance? A longitudinal follow-up study. J Nutr Health Aging 2003;7:153-159.
23. Dufouil C, Alpérovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003;53:214-221.
24. Sachdev PS, Valenzuela M, Wang XL, et al. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 2002;58:1539-1541.
25. Williams JH, Pereira EAC, Budge MM, Bradley KM. Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. Age Ageing 2002;31: 440-444.
26. den Heijer T, Vermeer SE, Clarke R, et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 2003; 126:170-175.
27. Hogervorst E, Ribeiro HM, Molyneux A, et al. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (Leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 2002;59:787-793.
28. Vermeer SE, van Dijk EJ, Koudstaal PJ, et al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol 2002;51:285-289.
29. Selhub J, Bagley LC, Miller J, Rosenberg IH. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 2000;71(suppl):614S- 620S.
30. Carmel R, Jacobsen DW. Homocysteine in health and disease. Cambridge: Cambridge University Press, 2001:271-305.
31. Goodwin JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983;249:2917-2921.
32. La Rue A, Koehler KM, Wayne SJ, et al. Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am J Clin Nutr 1997;65:20-29.
33. Ueland PM, Nygård O, Vollset SE, Refsum H. The Hordaland Homocysteine Studies. Lipids 2001;36:S33-S39.
34. Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG. The cardiovascular disease study in Norwegian counties: background and organization. Acta Med Scand Suppl 1979;634:1-70.
35. Nygård O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526-1533.
36. Nurk E, Tell GS, Vollset SE, et al. Plasma total homocysteine and hospitalizations for cardiovascular disease: the Hordaland Homocysteine Study. Arch Intern Med 2002;162:1374-1381.
37. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370.
38. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69-77.
39. Kendrick DC. Kendrick cognitive tests for the elderly. Windsor: The NFER-NELSON Publishing Company, 1985.
40. Engedal K, Haugen PK, Gilje K, Laake P. Efficacy of short mental tests in the detection of mental impairment in old age. Compr Gerontol [A] 1988;2:87-93.
41. desRosiers G, Hodges JR, Berrios G. The neuropsychological differentiation of patients with very mild Alzheimer's disease and/or major depression. J Am Geriatr Soc 1995;43: 1256-1263.
42. Refsum H, Ueland PM, Svardal AM. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem 1989;35:1921-1927.
43. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993;39:263-271.
44. O'Broin S, Kelleher B. Microbiological assay on microtitre plates of folate in serum and red cells. J Clin Pathol 1992;45: 344-347.
45. Kelleher BP, O'Broin SD. Microbiological assay for vitamin B12 performed 96-well microtitre plates. J Clin Pathol 1991;44: 592-595.
46. Ocké MC, Schrijver J, Obermann-De Boer GL, et al. Stability of blood (pro)vitamins during four years of storage at -20°C: consequences for epidemiologic research. J Clin Epidemiol 1995;48:1077-1085.
47. Nurk E, Tell GS, Vollset SE, et al. Changes in lifestyle and plasma total homocysteine: the Hordaland Homocysteine Study. Am J Clin Nutr 2004;79:812-819.
48. Ulvik A, Ueland PM. Single nucleotide polymorphism (SNP) genotyping in unprocessed whole blood and serum by real-time PCR: application to SNPs affecting homocysteine and folate metabolism. Clin Chem 2001;47:2050-2053.
49. Ulvik A, Ren J, Refsum H, Ueland PM. Simultaneous determination of methylenetetrahydrofolate reductase C677T and factor V G1691A genotypes by mutagenically separated PCR and multiple-injection capillary electrophoresis. Clin Chem 1998;44:264-269.
50. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
51. Bjelland I, Tell GS, Vollset SE, et al. Folate, vitamin B12, homocysteine, and the MTHFR 677C→T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry 2003;60:618-626.
52. Koivisto K, Helkala E-L, Reinikainen KJ, et al. Population-based dementia screening program in Kuopio: the effect of education, age, and sex on brief neuropsychological tests. J Geriatr Psychiatry Neurol 1992;5:162-171.
53. Buckwalter JG, Sobel E, Dunn ME, et al. Gender differences on a brief measure of cognitive functioning in Alzheimer's disease. Arch Neurol 1993;50:757-760.
54. Rabbitt P, Donlan C, Watson P, et al. Unique and interactive effects of depression, age, socioeconomic advantage, and gender on cognitive performance of normal healthy older people. Psychol Aging 1995;10:307-313.
55. Buckwalter JG, Rizzo AA, McCleary R, et al. Gender comparisons of cognitive performances among vascular dementia, Alzheimer disease, and older adults without dementia. Arch Neurol 1996;53:436-439.
56. Clarke R, Lewington S, Donald A, et al. Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies. J Cardiovasc Risk 2001;8:363-369.
57. Kalmijn S, Launer LJ, Lindemans J, et al. Total homocysteine and cognitive decline in a community-based sample of elderly subjects. The Rotterdam Study. Am J Epidemiol 1999;150: 283-289.
58. Religa D, Styczynska M, Peplonska B, et al. Homocysteine, apolipoprotein E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 2003;16:64-70.
59. Malouf R, Grimley EJ, Areosa SA. Folic acid with or without vitamin B12 for cognition and dementia (Cochrane review). In: The Cochrane Library. Issue 3. Chichester, UK: John Wiley & Sons, 2004.
60. Snowdon DA, Tully CL, Smith CD, et al. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun Study. Am J Clin Nutr 2000;71: 993-998.
61. 12 and folate in relation to the development of Alzheimer's disease. Neurology 2001;56:1188-1194.
62. Basun H, Fratiglioni L, Winblad B. Cobalamin levels are not reduced in Alzheimer's disease: results from a population-based study. J Am Geriatr Soc 1994;42:132-136.
63. 12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 1994;42:933-936.
64. Björkstén KS, Dige N, Nexø E. Long-term memory correlates negatively with plasma transcobalamin in healthy elderly with normal plasma cobalamin levels. Int J Geriatr Psychiatry 2001; 16:439-441.
65. Refsum H, Smith AD. Low vitamin B-12 status in confirmed Alzheimer's disease as revealed by serum holotranscobalamin. J Neurol Neurosurg Psychiatry 2003;74:959-961.
66. Gussekloo J, Heijmans BT, Slagboom PE, et al. Thermolabile methylenetetrahydrofolate reductase gene and the risk of cognitive impairment in those over 85. J Neurol Neurosurg Psychiatry 1999;67:535-538.
67. Visscher PM, Tynan M, Whiteman MC, et al. Lack of association between polymorphisms in angiotensin-converting-enzyme and methylenetetrahydrofolate reductase genes and normal cognitive ageing in humans. Neurosci Lett 2003;347: 175-178.
68. Yoo J-H, Choi G-D, Kang S-S. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. Arterioscler Thromb Vasc Biol 2000;20:1921-1925.
69. Bottiglieri T, Parnetti L, Arning E, et al. Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia. Mech Ageing Dev 2001;122: 2013-2023.
70. Ueland PM, Refsum H, Beresford SAA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000;72:324-332.
71. Klerk M, Verhoef P, Clarke R, et al. MTHFR 677C→T polymorphism and risk of coronary heart disease. A meta-analysis. JAMA 2002;288:2023-2031.
72. Malouf R, Areosa SA. Vitamin B12 for cognition (Cochrane review). In: The Cochrane Library. Issue 3. Chichester, UK: John Wiley & Sons, 2004.
73. Garcia A, Haron Y, Pulman K, et al. Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study. J Gerontol A Biol Sci Med Sci 2004;59A:1323-1327.